Nora Therapeutics To Present At The 21st Annual Future Leaders In The Biotech Industry Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PALO ALTO, Calif., March 21, 2014 /PRNewswire/ -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today that CEO Jeffrey K. Tong, Ph.D., is scheduled to present at the 21st Annual Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel in New York City on Friday, March 28, 2014 at 3:20 p.m. EDT.

About Nora Therapeutics, Inc.
Nora Therapeutics is a privately-held biotechnology company focused on developing therapeutics to address IVF failure and recurrent pregnancy loss, two reproductive conditions with significant unmet need. Nora's lead compound, NT100, is a novel biologic agent similar to a naturally occurring protein in the female reproductive tract and may better enable embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance. For more information, please visit our website at www.noratherapeutics.com.

SOURCE Nora Therapeutics



Help employers find you! Check out all the jobs and post your resume.

Back to news